Hi! I have sequenced entire genome of S.cerevisiae with Illumina and have paired end data. Now I am supposed to locate any translocation present in the genome. First I was planning to search for the regions that have higher coverage. My translocated strain did not sporulate and it just divided by mitosis as diploids. Since translocation results in transferring one part of chromosome to another, when I obtain fragments from entire genome to sequence, the number of translocated sequence doesnt change so the coverage should not be high in that regions. Now I am planning to search for the reads that have mate pairs in different chromosomes. Please tell me if my ideas are reasonable.
-
-
Illumina coverage is very nonuniform, particularly with amplified data (which yours may or may not be); also, features like can cause high coverage. I think you'll get too much noise to see any signal.
Looking for mate pairs on different chromosomes is better. Perhaps you could map the reads, filter for only reads that are improper pairs, and then look at the coverage for just those - they should be high in areas of translocations, and very low everywhere else. -
Thanks for your reply! I am confused in this point, why should I expect high coverage in translocated regions? How can it be considered as amplified sequences if it was just moved from one chromosome to another?Comment
-
You could describe the average coverage and sequencing length of your data to help people think more precisely.Originally posted by Bakhtiyar Taghizada View PostComment
-
Improperly paired reads are more likely to come from translocations. Thus, if you filter and look at only the improper pairs, coverage will be higher near translocations. The properly paired reads won't help you much.Originally posted by Bakhtiyar Taghizada View Post
Amplification is unrelated; it's part of library construction.How can it be considered as amplified sequences if it was just moved from one chromosome to another?Comment
-
Average coverage is around 40 and read length is around 100.Originally posted by woodydon View PostComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment